台灣外泌體技術，正走向全球！陞醫生技登上《Taiwan Business TOPICS》：From Anti-Aging to Biotech: Taiwan Looks to Take Its Exosomes Global

原文出處：《Taiwan Business TOPICS》by Laurel Stewart

The growing domestic medical aesthetics market has helped foster an increasingly sophisticated production ecosystem, creating opportunities in Taiwan and overseas.

Ms. Chen began looking into cosmetic treatments for fine lines and sun-related redness a couple of years ago. Together with her doctor, the 42-year-old settled on a treatment plan combining Pico laser with a topical exosome product. She says she’s happy with the results but cautions that the treatment’s effects take time to surface.

“Exosomes aren’t magic where your face is suddenly fuller the next day,” Chen says. “The improvement is subtle. Friends just think your skin looks great and no one asks if you’ve had work done.”

Her experience captures a shift taking place in Taiwan’s medical cosmetology industry: consumers are looking for less invasive ways to maintain their appearance, and biotechnology is the next frontier.

Exosomes have emerged at the center of that transition. These tiny, bubble-like particles are like cellular delivery trucks, carrying “packages” of biological materials like proteins, lipids, nucleic acids, and metabolites between cells. Researchers are investigating how exosomes function in processes including tissue repair, inflammation, and cellular communication. In aesthetics, exosome-based products are being marketed and studied for applications such as skin rejuvenation and hair care.

Topical exosome products are also often combined with Pico laser treatments, which use ultra-short pulses of energy to target pigmentation and create microscopic channels in the skin. Hsinchu-based dermatologist Dr. Lin Liang-chen says applying an exosome serum following this treatment can assist with recovery.

“After laser treatment, patients can have redness and itchiness for one to three weeks,” he says. “When we introduce exosome cosmetics, they can help reduce inflammation, improve the skin barrier, and support skin regeneration.”

For consumers like Chen, the appeal is less about dramatically changing how they look than maintaining healthy, youthful skin.

“Even if there are a few natural lines when laughing, it looks much better than a completely frozen face,” she says.

But exosomes are not the only example of biotech’s growing role in medical cosmetology. Treatments range from regenerative medicine and platelet-rich plasma treatments to bioengineered skin, peptides, growth factors, and extracellular vesicles (EV).

Still, exosomes provide a useful window into this emerging industry because their journey from laboratory to clinic involves a complex production process: cells must be cultured and harvested, EVs isolated and purified, products characterized and formulated, and the resulting ingredients or finished products distributed to clinics and consumers.

Taiwan already has many of these pieces in place. It has a mature cosmetics manufacturing sector, a substantial pharmaceutical and biotechnology industry, a sophisticated healthcare system, and a large domestic medical aesthetics market. The opportunity and the challenge, industry insiders say, is increasingly how to connect those existing strengths to global companies.

An aging local market

Taiwan’s rapidly aging population is also creating a growing market for products and services aimed at maintaining health and appearance later in life.

In 2026, Taiwan became a “super-aged” society, with people aged 65 and older accounting for more than 20% of the population. At the same time, the country’s fertility rate has continued to decline. According to data released by the Ministry of the Interior at the end of 2025, children aged 0-14 accounted for just 11.5% of the total population.

But an aging population is not necessarily synonymous with declining consumption. Taiwan’s older population has relatively high rates of homeownership, accumulated savings, and access to pensions. In 2024, the Industrial Technology Research Institute (ITRI) estimated that Taiwan’s “silver-haired economy” had a market potential of around NT$3.6 trillion (US$114 billion).

The changing demographic has coincided with a shift in consumer attitudes toward cosmetic procedures. Wallace Lin, Secretary-General of Taiwan BIO Industry Organization, says he’s seen an increase in people looking for a holistic approach to anti-aging.

閱讀全文